Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Expands-Pipeline-by-Signing-an-Option-Agreement-to-Acquire-an-Exclusive-License-with-COUR-Pharmaceuticals-to-Develop-and-Commercialize-CNP-104-for-the-Treatment-of-Primary-Biliary-Cholangitis-PBC-in-the-U.S/default.aspx